Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Letter
  • Published:

Mutations in SECISBP2 result in abnormal thyroid hormone metabolism

Abstract

Incorporation of selenocysteine (Sec), through recoding of the UGA stop codon, creates a unique class of proteins. Mice lacking tRNASec die in utero1, but the in vivo role of other components involved in selenoprotein synthesis is unknown, and Sec incorporation defects have not been described in humans. Deiodinases (DIOs) are selenoproteins involved in thyroid hormone metabolism. We identified three of seven siblings with clinical evidence of abnormal thyroid hormone metabolism. Their fibroblasts showed decreased DIO2 enzymatic activity not linked to the DIO2 locus. Systematic linkage analysis of genes involved in DIO2 synthesis and degradation led to the identification of an inherited Sec incorporation defect, caused by a homozygous missense mutation in SECISBP2 (also called SBP2). An unrelated child with a similar phenotype was compound heterozygous with respect to mutations in SECISBP2. Because SBP2 is epistatic to selenoprotein synthesis, these defects had a generalized effect on selenoproteins. Incomplete loss of SBP2 function probably causes the mild phenotype.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1: Selenoprotein synthesis, the feedback regulation of thyroid hormone synthesis and secretion, and its metabolism.
Figure 2: TFTs for family members and the effect of L-T4 and L-T3 on TSH suppression.
Figure 3: DIO2 enzymatic activity and mRNA expression in fibroblasts from two affected children (individuals III-2 and III-6 from family A, shown in duplicate) and six unaffected individuals (siblings III-3 and III-5 and mother and maternal uncle from family A and two unrelated normal individuals, shown as average results per individual from four independent experiments).
Figure 4: Linkage analysis of candidate genes and identification of SECISBP2 mutations.
Figure 5: TFTs for family members and identification of SECISBP2 mutations.
Figure 6: Effect of SBP2 defect on other selenoproteins and serum Se concentrations.

Similar content being viewed by others

References

  1. Bosl, M.R., Takaku, K., Oshima, M., Nishimura, S. & Taketo, M.M. Early embryonic lethality caused by targeted disruption of the mouse selenocysteine tRNA gene (Trsp). Proc. Natl. Acad. Sci. USA 94, 5531–5534 (1997).

    Article  CAS  Google Scholar 

  2. Kryukov, G.V. et al. Characterization of mammalian selenoproteomes. Science 300, 1439–1443 (2003).

    Article  CAS  Google Scholar 

  3. Schomburg, L., Schweizer, U. & Kohrle, J. Selenium and selenoproteins in mammals: extraordinary, essential, enigmatic. Cell. Mol. Life Sci. 61, 1988–1995 (2004).

    Article  CAS  Google Scholar 

  4. Moustafa, M.E. et al. Models for assessing the role of selenoproteins in health. J. Nutr. 133, 2494S–2496S (2003).

    Article  CAS  Google Scholar 

  5. Schweizer, U., Schomburg, L. & Savaskan, N.E. The neurobiology of selenium: lessons from transgenic mice. J. Nutr. 134, 707–710 (2004).

    Article  CAS  Google Scholar 

  6. Kumaraswamy, E. et al. Selective removal of the selenocysteine tRNA [Ser]Sec gene (Trsp) in mouse mammary epithelium. Mol. Cell. Biol. 23, 1477–1488 (2003).

    Article  CAS  Google Scholar 

  7. Carlson, B.A. et al. Specific excision of the selenocysteine tRNA[Ser]Sec (Trsp) gene in mouse liver demonstrates an essential role of selenoproteins in liver function. J. Biol. Chem. 279, 8011–8017 (2004).

    Article  CAS  Google Scholar 

  8. Carlson, B.A., Xu, X.M., Gladyshev, V.N. & Hatfield, D.L. Selective rescue of selenoprotein expression in mice lacking a highly specialized methyl group in selenocysteine tRNA. J. Biol. Chem. 280, 5542–5548 (2005).

    Article  CAS  Google Scholar 

  9. Weiss Sachdev, S. & Sunde, R.A. Selenium regulation of transcript abundance and translational efficiency of glutathione peroxidase-1 and -4 in rat liver. Biochem. J. 357, 851–858 (2001).

    CAS  PubMed  PubMed Central  Google Scholar 

  10. Hatfield, D.L. & Gladyshev, V.N. How selenium has altered our understanding of the genetic code. Mol. Cell. Biol. 22, 3565–3576 (2002).

    Article  CAS  Google Scholar 

  11. Driscoll, D.M. & Copeland, P.R. Mechanism and regulation of selenoprotein synthesis. Annu. Rev. Nutr. 23, 17–40 (2003).

    Article  CAS  Google Scholar 

  12. Bianco, A.C., Salvatore, D., Gereben, B., Berry, M.J. & Larsen, P.R. Biochemistry, cellular and molecular biology, and physiological roles of the iodothyronine selenodeiodinases. Endocr. Rev. 23, 38–89 (2002).

    Article  CAS  Google Scholar 

  13. Schussler, G.C. The thyroxine-binding proteins. Thyroid 10, 141–149 (2000).

    Article  CAS  Google Scholar 

  14. Dumitrescu, A.M., Liao, X.H., Best, T.B., Brockmann, K. & Refetoff, S. A novel syndrome combining thyroid and neurological abnormalities is associated with mutations in a monocarboxylate transporter gene. Am. J. Hum. Genet. 74, 168–175 (2004).

    Article  CAS  Google Scholar 

  15. Friesema, E.C. et al. Association between mutations in a thyroid hormone transporter and severe X-linked psychomotor retardation. Lancet 364, 1435–1437 (2004).

    Article  CAS  Google Scholar 

  16. Dumitrescu, A. et al. On the mechanism producing the unusual thyroid phenotype in defects of the MCT8 gene. Thyroid 14, 761 (2004).

    Google Scholar 

  17. Leonard, J.L. Dibutyryl cAMP induction of type II 5′deiodinase activity in rat brain astrocytes in culture. Biochem. Biophys. Res. Commun. 151, 1164–1172 (1988).

    Article  CAS  Google Scholar 

  18. Botero, D. et al. Ubc6p and ubc7p are required for normal and substrate-induced endoplasmic reticulum-associated degradation of the human selenoprotein type 2 iodothyronine monodeiodinase. Mol. Endocrinol. 16, 1999–2007 (2002).

    Article  CAS  Google Scholar 

  19. Curcio-Morelli, C. et al. Deubiquitination of type 2 iodothyronine deiodinase by von Hippel-Lindau protein-interacting deubiquitinating enzymes regulates thyroid hormone activation. J. Clin. Invest. 112, 189–196 (2003).

    Article  CAS  Google Scholar 

  20. Lescure, A., Allmang, C., Yamada, K., Carbon, P. & Krol, A. cDNA cloning, expression pattern and RNA binding analysis of human selenocysteine insertion sequence (SECIS) binding protein 2. Gene 291, 279–285 (2002).

    Article  CAS  Google Scholar 

  21. Copeland, P.R. Regulation of gene expression by stop codon recoding: selenocysteine. Gene 312, 17–25 (2003).

    Article  CAS  Google Scholar 

  22. Schneider, M.J. et al. Targeted disruption of the type 2 selenodeiodinase gene (DIO2) results in a phenotype of pituitary resistance to T4. Mol. Endocrinol. 15, 2137–2148 (2001).

    Article  CAS  Google Scholar 

  23. Olson, G.E., Winfrey, V.P., Nagdas, S.K., Hill, K.E. & Burk, R.F. Selenoprotein P is required for mouse sperm development. Biol. Reprod. 73, 201–211 (2005).

    Article  CAS  Google Scholar 

  24. Chu, F.F. et al. Bacteria-induced intestinal cancer in mice with disrupted Gpx1 and Gpx2 genes. Cancer Res. 64, 962–968 (2004).

    Article  CAS  Google Scholar 

  25. Schussler, G.C. & Plager, J.E. Effect of preliminary purification of 131-I-thyroxine on the determination of free thyroxine in serum. J. Clin. Endocrinol. Metab. 27, 242–250 (1967).

    Article  CAS  Google Scholar 

  26. Balzano, S. et al. Effect of total sleep deprivation on 5′-deiodinase activity of rat brown adipose tissue. Endocrinology 127, 882–890 (1990).

    Article  CAS  Google Scholar 

  27. Schomburg, L. et al. Gene disruption discloses role of selenoprotein P in selenium delivery to target tissues. Biochem. J. 370, 397–402 (2003).

    Article  CAS  Google Scholar 

Download references

Acknowledgements

We thank N.H. Scherberg and his laboratory staff for doing the tests of thyroid function in sera; all members of the families for their willingness to participate in this study; I. Abo Alnoor and A. Abomelha for their help and support; H. Hoey and M. Adress for referral of the proband of family B; M.-S. McPeek and U. Schweizer for advice; A. Hernandez and D. St. Germain for their efforts to measure DIO3 enzymatic activity in fibroblasts; J. Köhrle for his advice and help with selenoprotein analysis; K.J. Millen, G.I. Bell and D.F. Steiner for critical reading of the manuscript; F.E. Wondisford for contributing to Figure 1; and V.A. Galton for sharing with us unpublished data on the mice with combined Dio1 and Dio2 targeted disruption and for allowing us to mention these data as personal communication. This work was supported in part by grants from the US National Institutes of Health and from the Deutsche Forschungsgemeinschaft. A.M.D. is a Howard Hughes Medical Institute Predoctoral Fellow.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Samuel Refetoff.

Ethics declarations

Competing interests

The authors declare no competing financial interests.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Dumitrescu, A., Liao, XH., Abdullah, M. et al. Mutations in SECISBP2 result in abnormal thyroid hormone metabolism. Nat Genet 37, 1247–1252 (2005). https://doi.org/10.1038/ng1654

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/ng1654

This article is cited by

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing